Please provide your email address to receive an email when new articles are posted on . AIM-MASH AI Assist is the first AI drug development tool to be qualified by the FDA. The tool is designed to ...

If you click on links we provide, we may receive compensation. Shop the picks a pro calls "durable, reliable, and affordable" By Maggie Horton Maggie Horton has been baking for 20 years, and she’s ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

U.S. drugmaker Pfizer has clinched a $10 billion deal for obesity drug developer Metsera, capping a fierce biotech bidding war between the New York-based pharma giant and Danish rival Novo Nordisk.

To deploy AI tools securely and ethically, teams must balance innovation with accountability—establishing strong governance, upskilling developers, and enforcing rigorous code reviews. At this point, ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." I often think about my own soon-to-be 10-year-old, and if she’s somehow missing any of the big skills she ...

Business development companies have tumbled in recent weeks and now offer some of the highest yields in the stock market. For investors with tolerance for risk and volatility, BDCs offer plenty of ...

New commercial tenants, including Alo Yoga and an Apple Store, opened in downtown Detroit. Multiple apartment buildings, offering both market-rate and affordable housing, opened or reopened across the ...

A long-awaited $10 billion real-estate development under way in Beverly Hills is testing the limits of the wealthy California city’s appetite for luxury retail and residences. The 17.5-acre project ...

A July report by a team of Jefferies analysts paints an upbeat picture for contract development and manufacturing organizations (CDMOs). Miyabi Yamakita and colleagues reported rising demand for the ...